BerGenBio ASA (OSL: BGBIO)
Norway
· Delayed Price · Currency is NOK 10.37
+2.35 (29.37%)
Nov 21, 2024, 4:25 PM CET
BerGenBio ASA Income Statement
Financials in millions NOK. Fiscal year is January - December.
Millions NOK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Revenue | 0.52 | 0.35 | 0.39 | 0.77 | 0.6 | 8.9 | Upgrade
|
| Revenue Growth (YoY) | 33.93% | -9.00% | -49.74% | 28.79% | -93.25% | 281.16% | Upgrade
|
| Gross Profit | 0.52 | 0.35 | 0.39 | 0.77 | 0.6 | 8.9 | Upgrade
|
| Selling, General & Admin | 38.49 | 50.72 | 64.38 | 71.14 | 52.01 | 34.58 | Upgrade
|
| Other Operating Expenses | 122.87 | 141.23 | 240.76 | 242.79 | 208.95 | 177.91 | Upgrade
|
| Operating Expenses | 161.78 | 192.17 | 306.02 | 315.24 | 261.69 | 213.28 | Upgrade
|
| Operating Income | -161.26 | -191.82 | -305.63 | -314.46 | -261.09 | -204.38 | Upgrade
|
| Interest Expense | - | -0.58 | -0.32 | -0.05 | -0.03 | -0.11 | Upgrade
|
| Interest & Investment Income | 8.32 | 3.06 | 2.95 | 3.13 | 4.42 | 2.26 | Upgrade
|
| Other Non Operating Income (Expenses) | 0.65 | -1.06 | 0.88 | 2.02 | -0.33 | 2.94 | Upgrade
|
| Pretax Income | -152.29 | -190.4 | -302.12 | -309.36 | -257.03 | -199.28 | Upgrade
|
| Net Income | -152.29 | -190.4 | -302.12 | -309.36 | -257.03 | -199.28 | Upgrade
|
| Net Income to Common | -152.29 | -190.4 | -302.12 | -309.36 | -257.03 | -199.28 | Upgrade
|
| Shares Outstanding (Basic) | 32 | 14 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Outstanding (Diluted) | 32 | 14 | 1 | 1 | 1 | 1 | Upgrade
|
| Shares Change (YoY) | 305.85% | 1514.80% | 0.77% | 17.40% | 29.10% | 8.91% | Upgrade
|
| EPS (Basic) | -4.75 | -13.30 | -340.86 | -351.72 | -343.07 | -343.40 | Upgrade
|
| EPS (Diluted) | -4.75 | -13.30 | -340.86 | -351.72 | -343.07 | -343.40 | Upgrade
|
| Free Cash Flow | -138.99 | -225.1 | -288.23 | -303.34 | -234.36 | -186.68 | Upgrade
|
| Free Cash Flow Per Share | -4.33 | -15.73 | -325.18 | -344.87 | -312.81 | -321.70 | Upgrade
|
| Gross Margin | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | 100.00% | Upgrade
|
| Operating Margin | -30951.06% | -54186.16% | -78569.15% | -40628.29% | -43442.76% | -2296.35% | Upgrade
|
| Profit Margin | -29230.13% | -53785.59% | -77666.32% | -39969.51% | -42766.89% | -2239.08% | Upgrade
|
| Free Cash Flow Margin | -26677.54% | -63587.85% | -74095.37% | -39191.21% | -38994.51% | -2097.56% | Upgrade
|
| EBITDA | -161.04 | -191.8 | -305.55 | -314.31 | -260.92 | -204.21 | Upgrade
|
| D&A For EBITDA | 0.21 | 0.02 | 0.08 | 0.15 | 0.17 | 0.17 | Upgrade
|
| EBIT | -161.26 | -191.82 | -305.63 | -314.46 | -261.09 | -204.38 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.